Effects of pranlukast, a cysteinyl leukotriene antagonist, on bronchial responsiveness to methacholine in aspirin-intolerant asthmatics treated with corticosteroids

Hiroshima Journal of Medical Sciences

Volumn 49, Issue 2, 2000, Pages 105-108

  Ishioka, Shinichi ^a   Hozawa, Soichiro ^a   Haruta, Yoshinori ^a   Maeda, Akihiro ^a   Tamagawa, Kotaro ^a   Watanabe, Tetsuya ^a   Hiyama, Keiko ^a   Yamakido, Michio ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Aspirin intolerant asthma; Bronchial responsiveness; Cysteinyl leukotriene; Pranlukast

Indexed keywords

ACETYLSALICYLIC ACID; METHACHOLINE; PEPTIDOLEUKOTRIENE; PRANLUKAST;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION TEST; MALE;

ADRENAL CORTEX HORMONES; ADULT; AGED; ASPIRIN; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHROMONES; DRUG TOLERANCE; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED;

EID: 0033928111     PISSN: 00182052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 4 in subjects with aspirin-induced asthma. Am. Rev. Respir. Dis. 140: 148-153.
2. 4) and histamine in aspirin-sensitive asthmatic subjects. Eur. Respir. J. 6: 1468-1473.
3. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am. Rev. Respir. Dis. 143: 1025-1029.
4. 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J. Clin. Invest. 101: 834-846.
5. Dahlen, B., Kumlin, M., Margolskee, D.J., Larsson, C., Blomqvist, H., Williams, V.C., Zetterstrom, O. and Dahlen, S.E. 1993. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. Eur. Respir. J. 6: 1018-1026.
6. Dahlen, B., Nizankowska, E., Szczeklik, A., Zetterstrom, O., Bochenek, G., Kumlin, M., Mastalerz, L., Pinis, G., Swanson, L.J., Boodhoo, T.I., Wright, S., Dube, L.M. and Dahlen, S.E. 1998. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am. J. Respir. Crit. Care Med. 157: 1187-1194.
7. Fujimura, M., Sakamoto, S., Kamio, Y. and Matsuda, T. 1993. Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma. Respir. Med. 87: 133-138.
8. Hozawa, S., Haruta, Y., Ishioka, S. and Yamakido, M. 1995. Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma. Am. J. Respir. Crit. Care Med. 152: 1198-1202.
9. Israel, E., Fischer, A.R., Rosenberg, M.A., Lilly, C.M., Callery, J.C., Shapiro, J., Cohn, J., Rubin, P. and Drazen, J.M. 1993. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am. Rev. Respir. Dis. 148: 1447-1451.
10. 4 during aspirin-induced asthma. J. Lab. Clin. Med. 119: 48-51.
11. 4, and histamine in asthmatics. Am. Rev. Respir. Dis. 146: 96-103.
12. 4 in humans. Clin. Exp. Allergy 25: 467-479.
13. Makino, S., Kobayashi, S., Miyamoto, T., Shida, T. and Takahashi, S. 1982. Standard methods of provocation tests for asthma and hypersensitivity pneumonitis. Jpn. J. Allergol. 31: 1074-1076 (in Japanese).
14. Obata, T., Katsube, N., Miyamoto, T., Toda, M., Okegawa, T., Nakai, H., Kosuge, S., Konno, M., Arai, Y. and Kawasaki, A. 1985. New antagonists of leukotrienes: ONO-RS-411 and ONO-RS-347. Adv. Prostaglandin Thromboxane Leukot. Res. 15: 229-231.
15. 4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients. Int. Arch. Allergy Immunol. 113: 355-357.
16. Samter, M. and Beers, R.F., Jr. 1968. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann. Intern. Med. 68: 975-983.
17. Yamamoto, H., Nagata, M., Kuramitsu, K., Tabe, K., Kiuchi, H., Sakamoto, Y., Yamamoto, K. and Dohi, Y. 1994. Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078. Am. J. Respir. Crit. Care Med. 150: 254-257.